Perrigo Co. (PRGO) announced Tuesday morning that it filed an Abbreviated New Drug Application for over-the-counter Minoxidil topical aerosol foam 5%, a generic form of Men's Rogaine Foam.
Perrigo Co. posted modest gains early Tuesday, and broke out higher around the middle of the morning. The stock closed up by $0.90 at $37.09 on above average volume. Perrigo has been on an upward trend for nearly 2 months and set a new high for the year.
For comments and feedback: editorial@rttnews.com